...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 6%
6%
2
Dec 14, 2022 02:52PM

  "I wonder if they created ZE to limit what gets distributed to ZCC and to shareholders."

think u nailed it & belive we will find out sooner than later - your not the only ones whos been "wary of the company struture"


Dec 15, 2022 10:11AM
3
Dec 15, 2022 10:27AM

Dec 15, 2022 10:39AM
2
Dec 15, 2022 10:55AM
2
Dec 15, 2022 11:10AM
1
Dec 15, 2022 11:21AM
1
Dec 15, 2022 11:28AM
1
Dec 15, 2022 11:29AM
1
Dec 15, 2022 11:36AM
Share
New Message
Please login to post a reply